Adjunctive Chinese Herbal Medicine therapy improves survival of patients with chronic myeloid leukemia: a nationwide population‐based cohort study-Reference-Cited by-同舟云学术

Adjunctive Chinese Herbal Medicine therapy improves survival of patients with chronic myeloid leukemia: a nationwide population‐based cohort study

Published:2016-01-15 Issue:4 Volume:5 Page:640-648
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Fleischer Tom¹,Chang Tung‐Ti²³⁴,Chiang Jen‐Huai⁵⁶⁷,Chang Ching‐Mao⁸⁹,Hsieh Ching‐Yun¹⁰,Yen Hung‐Rong²³⁷¹¹^ORCID

Affiliation:

1. Graduate Institute of Chinese Medicine College of Chinese Medicine China Medical University Taichung Taiwan

2. Department of Chinese Medicine China Medical University Hospital Taichung Taiwan

3. School of Chinese Medicine China Medical University Taichung Taiwan

4. School of Post‐baccalaureate Chinese Medicine China Medical University Taichung Taiwan

5. Management Office for Health Data China Medical University Hospital Taichung Taiwan

6. Graduate Institute of Integrated Medicine College of Chinese Medicine China Medical University Taichung Taiwan

7. Research Center for Chinese Medicine and Acupuncture China Medical University Taichung Taiwan

8. Center for Traditional Medicine Taipei Veterans General Hospital Taipei Taiwan

9. Graduate Institute of Clinical Medicine Graduate Institute of Traditional Chinese Medicine College of Medicine Chang Gung University Taoyuan Taiwan

10. Division of Hematology and Oncology Department of Internal Medicine China Medical University Hospital Taichung Taiwan

11. Research Center for Traditional Chinese Medicine Department of Medical Research China Medical University Hospital Taichung Taiwan

Funder

China Medical University

Ministry of Health and Welfare

National Health Research Institutes

Publisher

Wiley

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.627

Reference23 articles.

1. Five-Year Follow-up of Patients Receiving Imatinib for Chronic Myeloid Leukemia

2. A Phase 2 Trial of Ponatinib in Philadelphia Chromosome–Positive Leukemias

3. A population study of imatinib in chronic myeloid leukaemia demonstrates lower efficacy than in clinical trials

4. International Randomized Study of Interferon Vs STI571 (IRIS) 8‐Year Follow up: sustained Survival and Low Risk for Progression or Events in Patients with Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase (CML‐CP) Treated with Imatinib;Deininger M.;ASH Ann.Meet. Abstr.,2009

5. Trends in the treatment changes and medication persistence of chronic myeloid leukemia in Taiwan from 1997 to 2007: a longitudinal population database analysis

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Utilization of Physiologically Based Pharmacokinetic Modeling in Pharmacokinetic Study of Natural Medicine: An Overview;Molecules;2022-12-08

2. A Review of the Pharmacological Potential of Spatholobus suberectus Dunn on Cancer;Cells;2022-09-15

3. Effect of Chinese Herbal Medicine Therapy on Risks of Overall, Diabetes-Related, and Cardiovascular Diseases-Related Mortalities in Taiwanese Patients With Hereditary Hemolytic Anemias;Frontiers in Pharmacology;2022-05-30

4. Physiologically based pharmacokinetic model predictions of natural product-drug interactions between goldenseal, berberine, imatinib and bosutinib;European Journal of Clinical Pharmacology;2022-01-20

5. Physiologically-Based Pharmacokinetic Predictions of the Effect of Curcumin on Metabolism of Imatinib and Bosutinib: In Vitro and In Vivo Disconnect;Pharmaceutical Research;2020-06-11